Prognostic impact of T-cell subsets and Epstein-Barr virus (EBV) infection in Hodgkin lymphoma

被引：0
作者：
Schreck, S.
Friebel, D.
Buettner, M.
Tegtmeier, S.
Distel, L.
Young, L. S.
Grabenbauer, G. G.
Niedobitek, G.
机构：
[1] Univ Klinikum Erlangen, Inst Pathol, Erlangen, Germany
[2] Univ Klinikum Erlangen, Strahlenklin, Erlangen, Germany
[3] Inst Canc Studies, Birmingham, W Midlands, England
来源：
PATHOLOGY RESEARCH AND PRACTICE | 2007年 / 203卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
55
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
[31]   Tumor-Associated Macrophages in Pediatric Classical Hodgkin Lymphoma: Association with Epstein-Barr Virus, Lymphocyte Subsets, and Prognostic Impact [J].
Barros, Mario Henrique M. ;
Hassan, Rocio ;
Niedobitek, Gerald .
CLINICAL CANCER RESEARCH, 2012, 18 (14) :3762-3771
[32]   Immunophenotypic and molecular analysis of Epstein-Barr virus (EBV)-positive cells in angioimmunoblastic T-cell lymphoma (AILT) [J].
Maeda, N ;
Ozawa, H ;
Yamashita, Y ;
Mori, N .
MODERN PATHOLOGY, 2002, 15 (01) :253A-253A
[33]   Influence of Epstein-Barr virus infection in adult T-cell leukemia [J].
Ueda, Satomi ;
Maeda, Yasuhiro ;
Yamaguchi, Terufumi ;
Hanamoto, Hitoshi ;
Hijikata, Yasuki ;
Tanaka, Miyako ;
Takai, Shunsuke ;
Hirase, Chikara ;
Morita, Yasuyoshi ;
Kanamaru, Akihisa .
HEMATOLOGY, 2008, 13 (03) :154-162
[34]   Quantification of Epstein-Barr Virus (EBV)-DNA in Peripheral Blood as Biomarker in Hodgkin Lymphoma [J].
Larocca, L. M. ;
Hohaus, S. ;
Cenci, T. ;
Martini, M. ;
Leone, G. .
LABORATORY INVESTIGATION, 2011, 91 :306A-306A
[35]   Quantification of Epstein-Barr Virus (EBV)-DNA in Peripheral Blood as Biomarker in Hodgkin Lymphoma [J].
Larocca, L. M. ;
Hohaus, S. ;
Cenci, T. ;
Martini, M. ;
Leone, G. .
MODERN PATHOLOGY, 2011, 24 :306A-306A
[36]   Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma [J].
Kikuchi, A ;
Anzai, H ;
Kosuge, H ;
Naka, W ;
Nishikawa, T .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) :124-128
[37]   Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma [J].
Gandhi, MK ;
Lambley, E ;
Burrows, J ;
Dua, U ;
Elliott, S ;
Shaw, PJ ;
Prince, HM ;
Wolf, M ;
Clarke, K ;
Underhill, C ;
Mills, T ;
Mollee, P ;
Gill, D ;
Marlton, P ;
Seymour, JF ;
Khanna, R .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :460-464
[38]   Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection [J].
Imai, S ;
Sugiura, M ;
Oikawa, O ;
Koizumi, S ;
Hirao, M ;
Kimura, H ;
Hayashibara, H ;
Terai, N ;
Tsutsumi, H ;
Oda, T ;
Chiba, S ;
Osato, T .
BLOOD, 1996, 87 (04) :1446-1457
[39]   Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis [J].
Fei, Qian ;
Tian, Xiao-Kang ;
Wu, Jing ;
Zhu, Hong-Ming ;
Wang, Yan ;
Peng, Fan-Yu ;
Zhang, Wen-Jun ;
Yin, Li ;
He, Xia .
ONCOTARGETS AND THERAPY, 2018, 11 :997-1004
[40]   Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma [J].
Kim, Yu Ri ;
Kim, Soo-Jeong ;
Cheong, June-Won ;
Chung, Haerim ;
Jang, Ji Eun ;
Kim, Yundeok ;
Yang, Woo-Ick ;
Min, Yoo Hong ;
Kim, Jin Seok .
ONCOTARGET, 2017, 8 (54) :92312-92323
12345